Zobrazeno 1 - 10
of 39
pro vyhledávání: '"59"'
Autor:
Luca Federici, Sebastiano Miscia, Nicola Tinari, Damiana Pieragostino, Pietro Di Marino, Luciana Irtelli, Rosalba Florio, Marco Marchisio, Antonino Grassadonia, Pasquale Simeone, Laura De Lellis, Paola Lanuti, Michele De Tursi, Maria Concetta Cufaro, Piero Del Boccio, Alessandro Cama, Serena Veschi, Giuseppina Bologna, Davide Brocco
Publikováno v:
Cancers, Vol 13, Iss 585, p 585 (2021)
Cancers
Volume 13
Issue 4
Cancers
Volume 13
Issue 4
Simple Summary Purpose of this study was to investigate the prognostic and predictive role of blood circulating extracellular vesicles (EVs) in patients with advanced non-small cell lung cancer treated with immunotherapy. A newly optimized flow cytom
Autor:
Seung Tae Kim, Won Ki Kang, Jun Su Park, Do Hoon Lim, Jun Ho Lee, Se Hoon Park, Jeong Il Yu, Jae Moon Bae, Jung Yong Hong, Ji Yeong An, Tae Sung Sohn, Jeeyun Lee, Heerim Nam, Min Gew Choi, Young-il Kim
Publikováno v:
Cancers
Volume 13
Issue 1
Cancers, Vol 13, Iss 59, p 59 (2021)
Volume 13
Issue 1
Cancers, Vol 13, Iss 59, p 59 (2021)
We investigated the incidence of renal function impairment after adjuvant treatment for gastric cancer and analyzed the impact of radiotherapy on estimated glomerular filtration rate (eGFR) five years after gastric surgery. We reviewed the medical re
Autor:
Charis Kalogirou, Britta Heinze, Armin Wiegering, Carmina Teresa Fuss, Stefanie Hahner, Katharina Other, Martin Fassnacht, Laura-Sophie Landwehr
Publikováno v:
Cancers
Volume 13
Issue 22
Cancers, Vol 13, Iss 5693, p 5693 (2021)
Volume 13
Issue 22
Cancers, Vol 13, Iss 5693, p 5693 (2021)
Background: The chemokine receptor CCR7 is crucial for an intact immune function, but its expression is also associated with clinical outcome in several malignancies. No data exist on the expression of CCR7 in adrenocortical tumors. Methods: CCR7 exp
Autor:
Fatima Laki, Youlia M. Kirova, Alain Fourquet, Jean-Yves Pierga, Anne Vincent-Salomon, Diane Jornet, Pierre Loap
Publikováno v:
Cancers
Volume 13
Issue 20
Cancers, MDPI, 2021, 13 (20), ⟨10.3390/cancers13205107⟩
Cancers, Vol 13, Iss 5107, p 5107 (2021)
Volume 13
Issue 20
Cancers, MDPI, 2021, 13 (20), ⟨10.3390/cancers13205107⟩
Cancers, Vol 13, Iss 5107, p 5107 (2021)
Simple Summary The originality of this prospective study is to use radiation therapy in association with chemotherapy before surgery and permit patients to preserve their breasts or to undergo immediate reconstruction. This neoadjuvant strategy can t
Autor:
Belinda Bauer, Christian Matula, Karl Rössler, Brigitte Gatterbauer, Ursula Schwarz-Nemec, Valerie Dahm, Alexander Wressnegger, Christoph Arnoldner, Erdem Yildiz, Wolfgang Gstoettner
Publikováno v:
Cancers
Volume 13
Issue 20
Cancers, Vol 13, Iss 5083, p 5083 (2021)
Volume 13
Issue 20
Cancers, Vol 13, Iss 5083, p 5083 (2021)
Simple Summary Temporal bone paragangliomas are rare benign skull base tumors. They are categorized according to Fisch or Glasscock–Jackson classification systems. The complexity of tumor location and extension into neighboring anatomical structure
Autor:
Priya Jayachandran, Shivani Soni, Francesca Battaglin, Jingyuan Wang, Satoshi Matsusaka, Wu Zhang, Masahiro Kozuka, Hiroyuki Arai, Heinz-Josef Lenz, Mitsuharu Hirai
Publikováno v:
Cancers
Volume 13
Issue 19
Cancers, Vol 13, Iss 4862, p 4862 (2021)
Volume 13
Issue 19
Cancers, Vol 13, Iss 4862, p 4862 (2021)
Simple Summary Circulating tumor cell (CTC) detection is a non-invasive and easy way to collect and separate single cells to use as tumor biomarkers. In this article, we show the feasibility and clinical value of RNA sequencing of CTCs at the single-
Autor:
Elisabet Cuyàs, Jose Carlos Ruffinelli, Eugeni López-Bonet, Alejandro Hernández-Martínez, Elia Sais, Maria Buxó, Teresa Moran, Javier A. Menendez, Angel Izquierdo, Enric Carcereny, Joaquim Bosch-Barrera, Ramon Palmero, Glòria Oliveras, Ernest Nadal, Sara Verdura
Publikováno v:
Cancers, Vol 13, Iss 4168, p 4168 (2021)
Cancers
Cancers; Volume 13; Issue 16; Pages: 4168
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Cancers, 2021, vol. 13, núm. 16, p. 4168
Articles publicats (IdIBGi)
Bosch Barrera, Joaquim Verdura, Sara Ruffinelli, José Carlos Carcereny, Enric Sais, Elia Cuyàs, Elisabet Palmero, Ramon López Bonet, Eugeni Hernández-Martínez, Alejandro Oliveras, Glòria Buxó Pujolràs, Maria Izquierdo i Font, Àngel Xavier Morán, Teresa Nadal, Ernest Menéndez Menéndez, Javier Abel 2021 Silibinin suppresses tumor cell-intrinsic resistance to Nintedanib and enhances its clinical cctivity in Lung Cancer Cancers 13 16 4168
DUGiDocs – Universitat de Girona
Cancers
Cancers; Volume 13; Issue 16; Pages: 4168
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Cancers, 2021, vol. 13, núm. 16, p. 4168
Articles publicats (IdIBGi)
Bosch Barrera, Joaquim Verdura, Sara Ruffinelli, José Carlos Carcereny, Enric Sais, Elia Cuyàs, Elisabet Palmero, Ramon López Bonet, Eugeni Hernández-Martínez, Alejandro Oliveras, Glòria Buxó Pujolràs, Maria Izquierdo i Font, Àngel Xavier Morán, Teresa Nadal, Ernest Menéndez Menéndez, Javier Abel 2021 Silibinin suppresses tumor cell-intrinsic resistance to Nintedanib and enhances its clinical cctivity in Lung Cancer Cancers 13 16 4168
DUGiDocs – Universitat de Girona
Simple Summary Nintedanib is an anti-angiogenic agent that has received approval in the European Union for the treatment of non-small cell lung cancer (NSCLC) after first-line chemotherapy. Here, we explore the possibility that the flavonolignan sili
Autor:
Christian Furth, Josefine Graef, Stephanie Bluemel, Uli Fehrenbach, Holger Amthauer, Julian M. M. Rogasch, Monique Tschernig, Imke Schatka, Bernhard Gebauer, Jalid Sehouli, J. U. Blohmer
Publikováno v:
Cancers
Volume 13
Issue 15
Cancers, Vol 13, Iss 3777, p 3777 (2021)
Volume 13
Issue 15
Cancers, Vol 13, Iss 3777, p 3777 (2021)
Selective internal radiation therapy (SIRT) is a therapy option in patients with breast cancer liver metastasis (BCLM). This analysis aimed at identifying a prognostic score regarding overall survival (OS) after SIRT using routine pretherapeutic para
Autor:
Joanna J. Phillips, Mitchel S. Berger, Barbara Kiesel, Anna S. Berghoff, Lisa I. Wadiura, Stefan Wolfsberger, Georg Widhalm, Julia Furtner, Arthur Hosmann, Matthias Millesi, Shawn L. Hervey-Jumper, Thomas Roetzer, Martin Borkovec, Mario Mischkulnig, Petra A. Mercea
Publikováno v:
Cancers, Vol 13, Iss 2540, p 2540 (2021)
Cancers
Volume 13
Issue 11
Cancers, vol 13, iss 11
Cancers
Volume 13
Issue 11
Cancers, vol 13, iss 11
The prediction of the individual prognosis of low-grade glioma (LGG) patients is limited in routine clinical practice. Nowadays, 5-aminolevulinic acid (5-ALA) fluorescence is primarily applied for improved intraoperative visualization of high-grade g
Autor:
Giorgio V. Scagliotti, Andrea Caglio, Tessa Sperone, Fabrizio Tabbò, Maria Lucia Reale, Francesco Passiglia, Massimo Di Maio, Paolo Bironzo, Angela Listì, Silvia Novello, Luisella Righi, Federico Bussolino
Publikováno v:
Cancers
Volume 13
Issue 10
Cancers, Vol 13, Iss 2425, p 2425 (2021)
Volume 13
Issue 10
Cancers, Vol 13, Iss 2425, p 2425 (2021)
Background: Tyrosine kinase inhibitors (TKIs) show variable efficacy in epidermal growth factor receptor mutation-positive (EGFR+) NSCLC patients, even in patients harbouring the same mutation. Co-alterations may predict different outcomes to TKIs. M